Boston Scientific Corporation
BSX
NYSE·Healthcare·Medical - Devices·Mkt cap $71.0B
$47.80
▲ +1.81%
P/E
19.35
Mkt Cap
$71.0B
52-Wk Range
$42.20–$109.50
52-Week Range
$42.20 - $109.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 55.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive medical device patent portfolio
- Global research and development capabilities
- Diversified product lines across multiple medical specialties
- Strong regulatory compliance and clinical validation
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging global population
Value
Attractively priced below Medical Devices peer average
Momentum
Stable
-1.9% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying BSX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
JUL 29, 2026
Reported EPS of $0.86 vs $0.84 consensus (+3.0% surprise). Revenue of $5.4B vs $5.4B expected (+1.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.0%
Revenue trend · last 8Q
—
+22%
+21%
+23%
+20%
+16%
+12%
+8%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$4.2B
$4.6B
$4.7B
$5.1B
$5.1B
$5.3B
$5.2B
$5.4B
Margins · last 8Q
Gross
70.7%
Operating
22.2%
Profit
16.7%
Wall Street consensus
22 analysts · 91% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
91%
Hold
9%
Sell
0%
Median Price Target
—
Latest: TD Cowen · Aug 25, 2026
vs Industry
How BSX stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related